Comments
Loading...
NovoCure (NASDAQ:NVCR) Stock Quotes, Forecast and News Summary
NovoCure Stock (NASDAQ: NVCR) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy NovoCure (NVCR) stock?
You can purchase shares of NovoCure (NASDAQ:NVCR) through any online brokerage.
Who are NovoCure (NVCR) competitors?
Other companies in NovoCure’s space includes: CeriBell (NASDAQ:CBLL), Axogen (NASDAQ:AXGN), Varex Imaging (NASDAQ:VREX), Envista Holdings (NYSE:NVST) and Inari Medical (NASDAQ:NARI).
What is the forecast, or price target, for NovoCure (NVCR) stock?
NovoCure has a consensus price target of $65.27.
What is the current price for NovoCure (NVCR)?
The stock price for NovoCure (NASDAQ: NVCR) is $16.695 last updated November 20, 2024 at 10:20 AM EST.
Does NovoCure (NVCR) pay a dividend?
There are no upcoming dividends for NovoCure.
When is NovoCure (NASDAQ:NVCR) reporting earnings?
NovoCure’s Q4 earnings are confirmed for Thursday, February 20, 2025.
Is NovoCure (NVCR) going to split?
There is no upcoming split for NovoCure.
What sector and industry does NovoCure (NVCR) operate in?
NovoCure is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.